We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.9B
AUM Growth
+$2.5B
Cap. Flow
+$1.34B
Cap. Flow %
6.41%
Top 10 Hldgs %
19.15%
Holding
3,219
New
357
Increased
1,640
Reduced
999
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 9.32%
2 Consumer Discretionary 5.02%
3 Financials 4.84%
4 Healthcare 4.11%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMF
2201
Templeton Emerging Markets Fund
EMF
$331M
$419K ﹤0.01%
21,185
+2,874
+16% +$56.4K
FEZ icon
2202
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
$418K ﹤0.01%
8,927
+3,380
+61% +$160K
ACH
2203
Accendra Health
ACH
$83.8M
$418K ﹤0.01%
9,874
+1,159
+13% +$45.1K
VGM icon
2204
Invesco Trust Investment Grade Municipals
VGM
$569M
$418K ﹤0.01%
29,802
MCA
2205
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$417K ﹤0.01%
+26,473
New +$403K
LAMR icon
2206
Lamar Advertising Co
LAMR
$15.8B
$415K ﹤0.01%
3,978
+124
+3% +$12.6K
SRPT icon
2207
Sarepta Therapeutics
SRPT
$1.96B
$414K ﹤0.01%
5,331
+365
+7% +$27.7K
FNI
2208
DELISTED
First Trust Chindia ETF
FNI
$414K ﹤0.01%
6,631
-1,590
-19% -$96.8K
BC icon
2209
Brunswick
BC
$5.29B
$413K ﹤0.01%
+4,149
New +$422K
EPR icon
2210
EPR Properties
EPR
$4.73B
$413K ﹤0.01%
7,848
+117
+2% +$5.82K
BSMN
2211
DELISTED
Invesco BulletShares 2023 Municipal Bond ETF
BSMN
$413K ﹤0.01%
16,110
+1
+0% +$26
CMA
2212
DELISTED
Comerica
CMA
$412K ﹤0.01%
5,777
+393
+7% +$29.1K
EQR icon
2213
Equity Residential
EQR
$24.7B
$412K ﹤0.01%
5,355
+98
+2% +$7.41K
FTV icon
2214
Fortive
FTV
$18.6B
$410K ﹤0.01%
7,809
-15,703
-67% -$846K
CARM
2215
DELISTED
Carisma Therapeutics
CARM
$409K ﹤0.01%
4,423
+2,631
+147% +$168K
RIV
2216
RiverNorth Opportunities Fund
RIV
$307M
$409K ﹤0.01%
22,295
+6,170
+38% +$110K
IBRX icon
2217
ImmunityBio
IBRX
$8.1B
$408K ﹤0.01%
+28,568
New +$472K
NXR
2218
DELISTED
NUVEEN ELECT TAX-FREE INC 3
NXR
$408K ﹤0.01%
21,814
+93
+0.4% +$1.67K
BURL icon
2219
Burlington
BURL
$22.4B
$407K ﹤0.01%
1,265
+13
+1% +$4.14K
IPAC icon
2220
iShares Core MSCI Pacific ETF
IPAC
$2.78B
$407K ﹤0.01%
6,140
+280
+5% +$18.8K
VAC icon
2221
Marriott Vacations Worldwide
VAC
$4.15B
$406K ﹤0.01%
2,546
-330
-11% -$56.5K
NPV icon
2222
Nuveen Virginia Quality Municipal Income Fund
NPV
$216M
$405K ﹤0.01%
24,459
+9,791
+67% +$160K
GERN icon
2223
Geron
GERN
$982M
$404K ﹤0.01%
286,621
-6,000
-2% -$8.73K
FFA
2224
First Trust Enhanced Equity Income Fund
FFA
$473M
$403K ﹤0.01%
19,849
-592
-3% -$11.7K
NYF icon
2225
iShares New York Muni Bond ETF
NYF
$1.41B
$403K ﹤0.01%
+6,902
New +$402K

Similar funds

Cambridge Investment Research Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Cambridge Investment Research Advisors held 3,219 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $1.34B of net new capital in Q2 2021, opening 357 new positions and adding to 1,640 existing holdings. Its largest new stake was Vanguard Morningstar Growth ETF: 2,637,318 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $17.7M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2021 buy was Vanguard Morningstar Growth ETF: 2,637,318 shares worth $126M.
  • Cambridge Investment Research Advisors added most to FS KKR Capital in Q2 2021, an estimated $36M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2021 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $17.7M.
  • Cambridge Investment Research Advisors fully exited Teucrium Corn Fund in Q2 2021, selling an estimated $4.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $20.9B portfolio in Q2 2021.
  • Cambridge Investment Research Advisors opened 357 new positions and closed 136 in Q2 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.